Request PDF on ResearchGate | Embarazo gemelar con feto sano y mola completa como origen de enfermedad trofoblástica gestacional persistente: caso . AMA Citation Enfermedad trofoblástica gestacional. In: Cunningham F, Leveno KJ, Bloom SL, Spong CY, Dashe JS, Hoffman BL, Casey BM, Sheffield JS. Doppler. Enfermedad trofoblástica gestacional F.J. Rodríguez- EscuderoEnfermedad trofoblástica persistente y metastásica. Sociedad Española de.
|Published (Last):||2 May 2006|
|PDF File Size:||10.18 Mb|
|ePub File Size:||3.88 Mb|
|Price:||Free* [*Free Regsitration Required]|
Clinical Trials Register
Clinical trials The European Union Clinical Trials Register allows you to search for protocol and results information on: Cancer AND drug name. Pneumonia AND sponsor name. How to search [pdf].
For these items you should use the filters and not add them to your search terms in the text field. Trials with results Trials without results Clear advanced search filters.
There was a problem providing the content you requested
Review by the Competent Authority or Ethics Committee in the country concerned. EU Clinical Trials Register.
Both Female Only Male Only. IMP with orphan designation in the indication. Trials with results Trials without results.
Clear advanced search filters. Date on which this record was first entered persistentte the EudraCT database:. Aspirin for the enhancement of trophoblastic invasion in women with abnormal uterine artery Doppler at weeks of gestation. Title of the trial for lay people, in easily understood, i.
Use of Aspirin to improve the transport of blood to the fetus in patients with altered Doppler US. The IMP has been designated in this indication as an orphan drug in the Community.
Committee on Advanced therapies CAT has issued a classification for this tgofoblastica. Combination product that includes a device, but does not involve an Advanced Therapy. Diseases [C] – Female diseases of the urinary and reproductive systems and pregancy complications [C13]. To establish wether a prophylactic intervention from first trimestre with low-dose of aspirine improves trophoblastic invasion evaluated at third trimester in women defined as high-risk by abnormal uterine artery Doppler at first trimester.
The trial involves single site in the Member State concerned. Enfermedav of the end of the trial and justification where it is not the last visit of the last subject undergoing the trial. Last visit of the last subject LVLS. Plans for treatment or care after the subject has ended the participation in the trial if enfermedaf is different from the expected normal treatment of that condition.